CIK: 0001865139
Total reported value
$395.7M
Reporting period: 2026-03-31 · Number of holdings: 1
Index Venture Life Associates VI Ltd disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $395.7M and a quarterly turnover rate of 45.5%.
Browse other institutions with $100M to $1B AUMBrowse other institutions starting with "I"
Sector classification currently covers about 0% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Unchanged 260
0.0% $146.5M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | 260 | Centessa Pharmaceuticals-adr | Stock-Other | 100.00% | — | — |
Performance for Q3 2026
—
Performance Last 4 Quarters
—
Based on 0 months of available history
Based on 0% of reported portfolio value with available pricing
Not enough sector-mapped data yet
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | 260 | Centessa Pharmaceuticals-adr | — | — | Unchanged |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-13 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-15 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-15 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-16 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001905393
Total reported value
$395.5M
164 stks
2026-03-31
AUM within 0.1% of this institution
CIK 0001507971
Total reported value
$395.1M
845 stks
2026-03-31
AUM within 0.2% of this institution
CIK 0001219573
Total reported value
$396.3M
1 stks
2026-03-31
AUM within 0.2% of this institution
Institutions with overlapping top holdings
CIK 0001224962
Total reported value
$5.1B
94 stks
2026-03-31
1 of the top 5 holdings overlap, including Centessa Pharmaceuticals-adr
CIK 0001587114
Total reported value
$2.4B
30 stks
2026-03-31
1 of the top 5 holdings overlap, including Centessa Pharmaceuticals-adr
CIK 0001600004
Total reported value
$1.1B
35 stks
2026-03-31
1 of the top 5 holdings overlap, including Centessa Pharmaceuticals-adr